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osting by EAbstract Silver has been used for the treatment of medical ailments for over 100 years due to its
natural antibacterial and antifungal properties. In this study, silver nanoparticles were synthesized,
evaluated for its wound healing activity and its effect in some functions of the liver and kidney. We
investigated the wound-healing properties of silver nanoparticles in an animal model and found that
rapid healing and improved cosmetic appearance occur within 15 days. Furthermore, we showed
that silver nanoparticles exert positive effects through their antimicrobial properties, reduction in
wound inﬂammation, and modulation in some of liver and kidney functions during skin wound
healing. These results have given insight into the actions of silver and have provided a novel ther-
apeutic direction for wound treatment in clinical practice.
ª 2010 King Saud University. All rights reserved.1. Introduction
Silver nanoparticles had been utilized in various aspects like
spectrally selective coating for solar energy absorption, optical
receptors, polarizing ﬁlters, catalysts in chemical reaction,
biolabelling and antimicrobial agents (Liechty et al., 2000).
Application of silver nanoparticles in these ﬁelds is dependent
on the ability to synthesize particles with different chemicality. All rights reserved. Peer-
d University.
lseviercomposition, shape, size and mono-dispersity. Development
of simple and ecofriendly method would help in developing
further interest in the synthesis and application of metallic
nanoparticles. The use of silver in the past has been restrained
by the need to produce silver as a compound, thereby increas-
ing the potential side effects. Nanotechnology has provided a
way of reducing pure silver nanoparticles. This system also
markedly increases the rate of silver on release.
The ultimate goal for wound healing is a speedy recovery
with minimal scarring and maximal function. Wound healing
proceeds through an overlapping pattern of events including
coagulation, inﬂammation, proliferation, matrix and tissue
remodeling.
Fan and Bard (1999) published studies of silver nanoparti-
cles on wound healing are sparse, and the mechanism of action
remains unknown. Herein we report that silver nanoparticles
can promote wound healing and reduce scar appearance in a
48 A. Hendidose-dependent manner. Furthermore, our studies show that
silver nanoparticles act by decreasing inﬂammation and no
side effect on the liver and kidney functions through rat model.
The potential beneﬁts of silver nanoparticles in all wounds can
therefore be enormous.Figure 1 UV–vis absorption spectra.
Figure 2 TEM image.2. Materials and methods
2.1. Animal experiment
Nine-week old Male Wistar rats (53.2–106.9 g) from the Laboratory
Animal Unit of King Saud University, Research centre – Saudi Arabia
– Riyadh. All animals were reared on a standard laboratory. They were
kept in a room where the temperature (20 ± 10 C), humidity (25–
35%), and day:night cycle (12:12 light:dark) were controlled.
Injury template was fashioned from a plastic 60-mL syringe by cut-
ting a window (10 · 5 mm) into the back with the opposite half re-
moved. The dorsum of each rat was carefully shaved beside the tail
and laid on the injury template following anaesthesia. This model
would achieve approximately 10% deep partial thickness injury of to-
tal body surface area. The rate was injected with sterile saline intraper-
itoneally (1 mL) for ﬂuid resuscitation.
2.2. Synthesis of silver nanoparticles
The formation of silver nanoparticles can be observedby a change in col-
or since small nanoparticles of silver are yellow. Add 30 mL of sodium
borohydride (NaBH4) to an Erlenmeyer ﬂask. Add a magnetic stir bar
and place the ﬂask in an ice bath on a stir plate. Stir and cool the liquid
for about 20 min. Drip 2 mL of silver nitrate (AgNO3) into the stirring
NaBH4 solution at approximately drop per second. Stop stirring as soon
as all of the AgNO3 is added. The addition of a few drops of 1.5 M so-
dium chloride (NaCl) solution causes the suspension to turn darker yel-
low, then gray as the nanoparticles aggregate. Transfer a small portion
of the solution to a test tube. Add a drop of 0.3% polyvinyl pyrrolidone
(PVP). PVP prevents aggregation. Addition of NaCl solution then has
no effect on the color of the suspension. Add enough solid polyvinyl
alcohol (PVA) to give a 4% solution (Solomon et al., 2007).
2.3. UV–visible spectral analysis
Inmetal nanoparticles such as in silver, the conduction band and valence
band lie very close to each other in which electrons move freely. These
free electrons give rise to a surface plasmon resonance (SPR) absorption
band (Taleb et al., 1998; Noginov et al., 2006; Link and El-Sayed, 2003;
Kreibig andVollmer, 1995), occurring due to the collective oscillation of
electrons of silver nano particles in resonance with the light wave (Nath
et al., 2007). Classically, the electric ﬁeld of an incoming wave induces a
polarization of the electrons with respect to much heavier ionic core of
silver nanoparticles. As a result a net charge difference occurs which in
turn acts as a restoring force. This creates a dipolar oscillation of all
the electrons with the same phase. When the frequency of the electro-
magnetic ﬁeld becomes resonant with the coherent electron motion, a
strong absorption takes place, which is the origin of the observed color.
Here the color of the prepared silver nanoparticles is dark reddish
brown. This absorption strongly depends on the particle size, dielectric
medium and chemical surroundings (Noginov et al., 2006; Link and El-
Sayed, 2003). Small spherical nano particles (<20 nm) exhibit a single
surface plasmonband (He et al., 2002). The absorption peak (SPR) is ob-
tained in the visible range at 410 nm in Fig. 1.With the abovementioned
concentration. The stability of silver nanoparticles is observed for
4 months and it shows a SPR peak at the same wavelength.
2.4. Transmission electron microscopy (TEM) analysis
A TEM image of the prepared silver nano particles is shown in the
Fig. 1. The Ag nano particles are spherical in shape with a smooth sur-face morphology. The diameter of the nano particles is found to be
approximately 9 nm. TEM image Fig. 2 also shows that the produced
nano particles are more or less uniform in size and shape.
2.5. Statistical analysis
The results were expressed as mean (mean ± SD). Data were analyzed
statistically using one-way analysis of variance followed by t test. A va-
lue of (P< 0.05) was considered statistically signiﬁcant.
3. Results
Silver nanoparticles promote healing and achieve better cos-
mesis. In our control model (Noginov et al., 2006) rats, the
deep partial-thickness wounds normally healed after
(27 ± 1.99) days. In animals treated with silver nanoparticles
(NP). A single dose of (5 g/kg) of body weight was orally ga-
vaged into (Moore and O’Garra, 1993) rats and observed for
any sign of toxicity for the next 14 days, these healed in
(16 ± 68) days, whereas (Fig. 3A). The rate of healing in the
two groups was also compared. As with healing time, rate of
Figure 3 Silver nanoparticles accelerate wound healing and achieve superior cosmetic outcome: (A) time taken for wounds to heal in
animals treated with silver nanoparticles (Np), and no treatment (NT). (B) The rate of wound healing in wound animals treated with (Np)
or no treatment (NT). (C) Photographs of wounds from animals treated with Np, or no treatment on days 0, 10, and 15 after burn injury.
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These observations indicate that wound healing is accelerated
by silver nanoparticles.
We next compared the appearance of healed wounds. We
found that wounds in the Np group showed the most resem-
blance to normal skin, with less hypertrophic scarring and
nearly normal hair growth on the wound surface, with a thin
epidermis and nearly normal hair follicles (Fig. 3C).
The inﬂammatory response is an important component of
wound healing. Within wounds, various inﬂammatory media-
tors are secreted to modulate the healing process.
In normal wound healing, the potential for pro- and anti-
inﬂammatory cytokines is certainly present, and the inﬂamma-
tory response is entirely appropriate.
To accomplish successful wound repair and tissue regener-
ation, the inﬂammatory response must be tightly regulated
in vivo. Among the contributors to delayed wound healing,
prolonged inﬂammatory response is undoubtedly one of the
important factors.
A vital mediator in this anti-inﬂammatory cascade appears
to be IL-10, which can be produced by keratinocytes as well as
inﬂammatory cells involved in the healing process, including T
lymphocytes, macrophages, and B lymphocytes (Moore and
O’Garra, 1993). One of the unique actions of IL-10 is its ability
to inhibit the synthesis of pro-inﬂammatory cytokines which
also include IL-6 (Fiorentino et al., 1991; de Waal Malefyt
et al., 1991). IL-10 also inhibits leukocyte migration toward
the site of inﬂammation, in part, by inhibiting the synthesis
of several chemokines, including monocyte chemo attractantprotein-1 (MCP-1) and macrophage inﬂammatory protein-1a
(MIP-1a).
Both of the C–C chemokines promote monocyte accumula-
tion, and MIP-1a is also a potent neutrophil chemoattractant
in rats (Ajuebor et al., 1999). Moreover, studies have shown
that MCP-1 and MIP-1a play prominent roles in macrophage
recruitment into wounds during wound repair (Alam et al.,
1994). Within wounds, IL-6 is also secreted by polymer phonu-
clear cells (PMNs) and ﬁbroblasts. IL-6 has been recognized as
an initiator of events in the physiological alterations of inﬂam-
mation after injury (DiPietro, 1995; Engelhardt et al., 1998). In
fact, an increase in IL-6 concentration parallels the increase in
PMN count locally within acute wounds. IL-6 promotes
inﬂammation through monocyte and macrophage chemotaxis
and activation (Paquet and Pie´rard, 1996). Decreased IL-6
may result in fewer neutrophils and macrophages recruited
to the wound and less cytokines being released in the wound
with subsequently lower paracrine stimulation of cellular pro-
liferation, ﬁbroblast and keratinocyte migration, and extracel-
lular matrix production (Biswas et al., 1998). This lack of
ampliﬁcation of the inﬂammatory cytokine cascade may be
important in providing a permissive environment for scar less
wound repair to proceed. Silver induced neutrophil apoptosis
and decreased MMP activity may also contribute to the overall
decrease in the inﬂammatory response and as a consequence,
an increased rate of wound healing.
In the study reported herein, better cosmetic appearance
was observed in animals treated with silver nanoparticles. In
terms of wound healing, enhanced expression of TGF-
Table 3 Liver function changes in (Np and NT) group.
Time 1 day 7 day 15 day
GOT (Np) 167 182.58 162.2
50 A. Hendib1mRNA is found in both keloids and hypertrophic scars.
Cumulative evidence has suggested that TGF-b1 plays an
important role in tissue ﬁbrosis and post-injury scarring. We
think that lower levels of TGF-b coincided temporally with
increased levels of IFN-g until wound closure in the ND
group.
As IFN-g has been demonstrated as a potent antagonist of
ﬁbro genesis through its ability to inhibit ﬁbroblast prolifera-
tion and matrix production, its control on TGF-b production
may play a role (Duncan and Berman, 1985).
3.1. Body weight gain
The body weight gain of rats treated with silver nanoparticles
(Np) was similar to that of controls no treatment (NT) (Tables
1 and 2) while combined administration of this treatment
resulted in a signiﬁcant progress ready during the ﬁrst 2
weeks.
The ﬁnal body weight of the rats was un treated increase by
34%, 35%, 36% and 42% (P< 0.0001). This difference is
considered to be extremely statistically signiﬁcant. The analysis
of variance has shown that increase in body weight gain. While
the experimental group treated with silver nanoparticles had
increased in body weight gain 39%, 41%, 45% and 51%
(P< 0.0001). This difference is considered to be extremely sta-
tistically signiﬁcant. The increase in body weight gain the same
result between two group (ND and NT) an effects the silver
nanoparticles was also noted.Table 1 Body weight gain for control group (1). No
treatment.
Test 1 2 3 4 5
Weight before treatment (g) 91.9 85.1 101.8 106.9 89.4
Weight after treatment (g) 141.7 145.9 158.2 162.8 140.4
Intermediate values used in calculations:
t= 27.5266, df = 4, standard error of diﬀerence = 1.990
Group Group one Group two
Mean 95.020 149.800
SD 9.039 10.109
SEM 4.042 4.521
N 5 5
Table 2 Body weight gain for experimental group (2). Treatment w
Test 1 2 3 4
Weight before treatment (g) 82.8 70.1 53.2 83.
Weight after treatment (g) 120.3 119.7 108.4 159.
Intermediate values used in calculations:
t= 7.9659, df = 18, standard error of diﬀerence = 6.858
Group Group on
Mean 67.630
SD 10.812
SEM 3.419
N 103.2. Liver function changes
GPT were signiﬁcantly increased after 7th day and 15th days
to experimental group (NP) when compared with the control
group (NT) (Table 3, Figs. 4 and 5).
GOT were signiﬁcantly increased after 7th day and then de-
creased 15th days to experimental group (NP) and the control
group (NT) Table 3.
Glutamic–pyruvic transaminase (GPT) – also known as
alanine aminotransferase or ALT – is a cytoplasmic hepatocel-
lular enzyme, whose increase in blood is highly indicative for
liver damage e.g. by hepatitis, cirrhosis or hepatic tumors.
Changes of liver function (GPT) no differed among rats
treated with silver nanoparticles (Np), and rats no treatment
with silver nanoparticles (NT). Unpaired t test results this dif-
ference is considered to be not statistically signiﬁcant (95%)
(t= 0.1125, df = 13, standard error of difference = 5.069).
In most types of liver disease (GPT) activity is higher than
that of glutamicoxaloacetic transaminase (GOT); an exception
is in alcoholic hepatitis. The ratio of GPT and GOT may pro-
vide further information about the severity of the disease and
may serve as a prognostic indicator (Tables 4 and 5).ith silver nanoparticles (Np).
5 6 7 8 9 10
1 74 63.7 65.5 72.2 58 53.7
5 128.7 121.5 129.3 138.4 105.5 91.3
e Group two
122.260
18.800
5.945
10
GPT (Np) 25.38 27.78 32.16
GOT (NT) 152.11 161.1 155.1
GPT (NT) 22.26 33.71 24.27
Figure 4 The value of (GOT and GPT) liver function in (1, 7,
and 15) for the two groups.
Figure 5 The value of (Got, GPT).
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treated with silver nanoparticles (Np), and rats no treatment
with silver nanoparticles (NT). Unpaired t test results this dif-
ference is considered to be not statistically signiﬁcant (95%)
t= 0.4511, df = 13, standard error of difference = 16.139.
3.3. Kidney function changes
Urea is a waste product formed from the breakdown of pro-
teins. Urea is usually passed out in the urine. A high blood le-
vel of urea (‘uraemia’) indicates that the kidneys may not beTable 4 Unpaired t test (GPT) between two gruops.
Group Group one Group two
Mean 28.420 27.850
SD 12.163 7.612
SEM 5.440 2.407
N 5 10
Table 5 Unpaired t test (GOT) between two gruops.
Group Group one Group two
Mean 170.580 163.300
SD 29.796 29.319
SEM 13.325 9.271
N 5 10
Table 6 Changes of some kidney function to the control
group.
Test 1 2 3 4 5
Creatinine <44.2 <44.2 <44.2 <44.2 <44.2
Urea 50.3 54.1 52.2 47.5 55.6
Table 7 Changes of some kidney function to the experimental grou
Test 1 2 3 4 5
Creatinine <44.2 <44.2 <44.2 <44.2 <4
Urea 61 46.9 52.8 50.4 47.8working properly, or that you are dehydrated (have a low
body water content). Creatinine is a waste product made by
the muscles. Creatinine passes into the bloodstream, and is
usually passed out in urine. A high blood level of creatinine
indicates that the kidneys may not be working properly. Cre-
atinine is usually a more accurate marker of kidney function
than urea.
Changes of some kidney function (creatinine and urea) no
differed among rats treated with silver nanoparticles (Np),
and no treatment (NT) Tables 6 and 7.
Unpaired t test results (95%) this difference is considered to
be not statistically signiﬁcant (t= 1.0430, df = 13, standard
error of difference = 2.560) Table 8 and the same level of cre-
atinine (Tables 6 and 7).
3.4. Size of the lesion
Size of the lesion for experimental group (P< 0.0001). By
conventional criteria, this difference is considered to be extre-
mely statistically signiﬁcant (95%) (t= 8.4459, df = 12, stan-
dard error of difference = 0.399) (Table 9).
Size of the lesion for control group (P< 0.0001). By con-
ventional criteria, this difference is considered to be extremelyp.
6 7 8 9 10
4.2 <44.2 <44.2 <44.2 <44.2 <44.2
45.5 52.7 46.5 42.8 46.3
Table 8 Unpaired t test between two groups.
Group Group one Group two
Mean 51.940 49.270
SD 3.183 5.201
SEM 1.424 1.645
N 5 10
Table 9 Paired t test for experimental group.
Group Group one Group two
Mean 6.2777 2.9092
SD 3.4212 2.1436
SEM 0.9489 0.5945
N 13 13
Table 10 Paired t test for control group.
Group Group one Group two
Mean 7.6700 2.9810
SD 2.2265 1.8288
SEM 0.4979 0.4089
N 20 20
Table 11 Size of lesion between two groups (NT) and (Np).
Time Experiment (NP) Control (NT)
Length (mm) Width (mm) Length (mm) Width (mm)
Day 1 10.16 5.5 10.7 5.54
Day 2 10.1 5.68 10.64 5.5
Day 3 9.59 5.24 10.46 5.24
Day 4 8.93 4.67 10.3 5.1
Day 5 8.42 4.16 10.02 4.92
Day 8 7.49 3.49 9.4 4.42
Day 9 7 3.06 9.02 4.18
Day 10 6.17 2.49 8.78 3.9
Day 11 5.53 1.86 8.52 3.64
Day 12 9.88 1.21 7.88 3.16
Day 15 2.63 0.16 7.36 2.62
Day 16 0.67 0 6.96 2.3
Day 17 0.04 0 6.7 2.16
Day 18 6.5 2
Day 19 6.12 1.74
Day 22 5.68 1.24
Day 23 5.24 0.96
Day 24 4.78 0.6
Day 25 4.38 0.34
Day 26 3.86 0.02
Figure 6 Size of lesion length and width between two groups.
Figure 7 Length and width between two groups.
52 A. Hendistatistically signiﬁcant (95%, t= 51.8715, df = 19, standard
error of difference = 0.090) (Table 10) and that mean when
we use silver nanoparticles we found. The rate of healing
was increased in animals treated with NP. These observations
indicate that wound healing is accelerated by silver nanoparti-
cles (Table 11, Figs. 6 and 7).References
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